TIGECYCLINE
Generic: TIGECYCLINE
Meitheal Pharmaceuticals Inc.Manufacturer
INTRAVENOUSRoute
TIGECYCLINEActive Substance
2021-05-13Original Approval
TIGECYCLINE is FDA application ANDA214020, sponsored by MEITHEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
618 reports
2
OFF LABEL USE
542 reports
3
NAUSEA
299 reports
4
DRUG RESISTANCE
206 reports
5
SEPSIS
205 reports
6
VOMITING
202 reports
7
THROMBOCYTOPENIA
188 reports
8
SEPTIC SHOCK
182 reports
9
PATHOGEN RESISTANCE
171 reports
10
PRODUCT USE IN UNAPPROVED INDICATION
159 reports